University Hospital for Psychiatry II

301408, 301905, 302045, 302046, 302055, 302065, 302067, 302084, 303028, 305901, 305908, 305909, 501010, 501019, 503006, 509026

behavioural medicine, climate change, digital technologies, eating disorders, mental stress, patient reported outcomes, psycho-oncology, psychoneuroimmunology, psychotherapy, and sports psychiatry

Psychosomatic Medicine promotes inter- and transdisciplinary research at the intersection of somatic and mental health. Our focus is on disorders that manifest with both physical and mental symptoms, such as eating disorders, stress-related disorders and anxiety disorders. We explore psychoneuroimmunological mechanisms and innovative treatments, including physical activity and novel psychotherapeutic approaches. We develop and implement patient-reported outcomes and digital health tools across medical specialties. Our research extends to the well-being of medical students.

The University Hospital for Psychiatry II is a tertiary reference centre in the field of Psychosomatic Medicine. We provide comprehensive diagnostic work-ups and multimodal therapy programs that incorporate both cognitive-behavioural and psychodynamic approaches. We integrate evidence-based treatment guidelines and best practices into personalised treatment plans for patients with stress-related and associated disorders. Our clinical services include in-patient, day-patient, and out-patient programs, as well as a psychiatric-psychological consultation/liaison service.

Our research explores the complex interactions among physical, mental, and social conditions that contribute to psychosomatic and somatopsychic comorbidities. Using interdisciplinary and transdisciplinary approaches, our research fosters innovative collaborations across specialties. The University Hospital for Psychiatry II is also home to the Health Outcome Research Unit, which focuses on patient-centred treatment evaluation from a biopsychosocial perspective and promotes digitisation in medicine.

Eating Disorders

Contact Person: Barbara Mangweth-Matzek

Our research on eating disorders covers both psychological and physiological aspects: 1) Long term eating disorders, including severe and enduring eating disorders with a focus on childhood trauma, social relationships, body image, self-care, puberty, sexuality, pregnancy and menopause; 2) Remitted eating disorders; 3) Various stages of menopause and eating disorders; 4) Eating disorders in males and 5) Research on obese patients with bariatric surgery.

Clinical Psychology and Behavioural Medicine in specific settings

• Behaviour change in times of climate change
  Contact Person: Katharina Hüfner
  Climate change is a threat to the fragile alpine ecosystem, increasing stress and challenging our (mental) health. In a transdisciplinary approach, we explore factors of transformative climate action and resilience and investigate factors influencing behaviour change.
• Otolaryngology
  Contact Person: Roland Moschèn
  The field of behavioural medicine and clinical psychology in otolaryngology has a specific focus on tinnitus. Our research identifies the individual coping strategies employed by people with chronic tinnitus, particularly in phases of heightened tinnitus perception.
• Transplant Medicine
  

  

  Contact Person: Martin Kumnig –
  Vascularised composite allotransplantation (VCA) is a promising reconstructive transplantation technique. Recent research investigates the role of team science, interdisciplinary cooperation and communication, and shared decision-making, when establishing and maintaining a VCA program.

Health Outcome Research

Contact Persons: Bernhard Holzner, Johannes Giesinger

Over the past two years, the team has worked on a range of clinical and methodological projects. These have focused on advancing patient-reported outcome (PRO) research in chronic diseases. The work is structured around several key research areas of our dedicated Health Outcome Research Unit:

• Methodological Aspects of PRO Research
  Contact persons: Monika Sztankay, Lisa Wintner
  This area focuses on developing PRO questionnaires, communication tools and harmonising terminology related to PRO score interpretation thresholds. The SISAQOL-IMI project (sisaqol-imi.org) is a prime example. It also involves establishing robust guidelines for interpreting PRO data and constructing resources like the newly developed EORTC Reference Values Database.
• Psychooncology and Health-Utility Research
  Contact persons: Eva Gamper, Anne Oberguggenberger
  This initiative gained real momentum with the onset of the COVID-19 pandemic, focusing on assessing psycho-oncological treatment needs. It also includes work on the health-utility instrument QLU-C10D, a cancer-specific preference-based measure.
• Electronic PRO Assessment Tools
  

  

  Contact person: Jens Lehmann
  This domain focuses on designing and deploying digital tools, such as the electronic patient portal at the Medical University/Tyrol Clinics. These tools collect real-world PRO data, supporting treatment, research and quality assurance.

Psychotherapy and Trauma Research

Contact Person: David Riedl

Our research follows a psychodynamic approach to developmental psychopathology. We examine how early adversity, such as neglect and abuse, affects personality development and contributes to mental and somatic disorders in adulthood. We also assess the effectiveness of multimodal interventions. Our goal is to identify general mechanisms of change in psychotherapy. Key topics include mentalisation, epistemic stance and gender-specific effectiveness of psychotherapy.

Sports Psychiatry

Contact person: Katharina Hüfner

Somatic symptoms such as acute mountain sickness that can occur at high altitude are well characterised. However, there is still much to be learned about psychiatric symptoms. We investigate the differential, possibly opposite effects of high and moderate altitude exposure on mental health in individuals with preexisting mental disorders. Together with research partners at Eurac Research in Bolzano, Italy, we are using the controlled environment of TerraXcube for experimental hypoxia exposure. We use therapeutic climbing to investigate the effects of exercise on anxiety disorders.

Stress-Related Disorders and Psychoneuroimmunology 

Mental stress is clearly linked to somatic and psychiatric morbidity, but we still do not understand the neurobiological pathways of these associations. Mental stress has a well-known immunomodulatory effect, which is a fundamental concept in psychoneuroimmunology. We investigate the effects of mental stress on individuals with post COVID conditions and neurotransmitter precursor amino acids. We also evaluate the effect of exercise interventions on neurotransmitter precursor amino acids in individuals with anxiety disorders.

Well-being of medical students

Contact persons: Alexandra Huber, Stefan Höfer

Medical students and hospital physicians face high stress and performance pressure. Despite studying health, managing the well-being of personal is often neglected in medical education. Since 2015, annual online surveys have examined the factors influencing well-being. Findings showed that character strengths positively correlate with well-being, enhancing work engagement. Recent results highlight significant impact of the SARS-CoV-2 pandemic on the mental health of Austrian medical students.

Eating Disorders:

• Kummer, KK; Mangweth-Matzek, B: Male eating disorders in midlife – possible links between excessive sports and hormones. Aging Male. 2023; 26(1); 2154571. DOI: 10.1080/13685538.2022.2154571
• Mangweth-Matzek, B.; Kummer KK; Hoek HW: Update on the epidemiology and treatment of eating disorders among older people. Curr Opin Psychiatry. 2023; 36(6); 405-411. doi: 10.1097/YCO.0000000000000893.

Clinical Psychology and Behavioral Medicine in specific settings

Behavior change in times of climate change

• Frick, M; Neu, L; Liebhaber, N; Sperner-Unterweger, B; Stötter, J; Keller, L; Hüfner, K: Why Do We Harm the Environment or Our Personal Health despite Better Knowledge? The Knowledge Action Gap in Healthy and Climate-Friendly Behavior. Sustainability. 2021; 13; 13361. https://doi.org/10.3390/su132313361
• Frick, M; Guggenberger, JA; Liebhaber, N; Michelsen, G; Oberauer, K; Schackmar, S; Schickl, M; Keller, L; Hüfner, K: Conceptual links between environmental psychology and climate change education to encourage climate-friendly behavior of young people. Is there a role for self-regulation? Environmental Education Research. 2025; Jan 25; https://doi.org/10.1080/13504622.2024.2448681

Transplant Medicine

• Kumnig, M; Kobler, C; Zaccardelli, A; Brandacher, G; Talbot, SG: Advancing vascularized composite allotransplantation: Essential factors for upper extremity transplant program development. Frontiers in Transplantation. 2024; 3. DOI: 10.3389/frtra.2024.1406626.
• Kumnig, M; Hummel, NR; Jowsey-Gregoire, SG; Zuo, K; Gordon, EJ; Talbot, SG: Editorial: Psychosocial and bioethical challenges and developments for the future of vascularized composite allotransplantation. Frontiers in Psychology. 2023; 14. DOI: 10.3389/fpsyg.2023.1186113.
• Hummel, NR; Zuo, KJ; Talbot, SG; Zimmermann, ZE; Katz, JN; Kinsley, SE; Kumnig, M: Psychosocial predictors in upper-extremity vascularized composite allotransplantation: A qualitative study of multidimensional experiences including patients, healthcare professionals, and close relatives. Frontiers in Psychology. 2023; 14. DOI: 10.3389/fpsyg.2023.1092725.

Health Outcome Research

Methodological Aspects of PRO Research

• Gross,F; Rasmussen, IML; Beisland, EG; Jorem, GT; Beisland, C; Pappot, H; Arraras, JI; Pe, M; Holzner, B; Wintner, LM; EORTC Quality of Life Group. Health-related Quality of Life Assessment in Renal Cell Cancer: A Scoping Review. Eur Urol Oncol. 2025; 8(1); 201-212. doi: 10.1016/j.euo.2024.09.007.
• Rothmund, M; Pilz, MJ; Schlosser, L; Arraras, JI; Groenvold, M; Holzner, B; van Leeuwen, M; Petersen, MA; Schmidt, H; Young, T; Rose, M; Cella, D; Giesinger, JM; EORTC Quality of Life Group. Equipercentile equating of scores from common patient-reported outcome measures of physical function in patients with cancer. J Clin Epidemiol. 2024; 165; 111203. doi: 10.1016/j.jclinepi.2023.10.019.
• Pe, M; Alanya, A; Falk, RS; Amdal, CD; Bjordal, K; Chang, J; Cislo, P; Coens, C: Dirven, L:, Speck, RM; Fitzgerald, K; Galinsky, J; Giesinger, JM; Holzner, B; Le Cessie, S; O’Connor, D; Oliver, K; Pawar, V: Quinten, C; Schlichting, M; Ren, J; Roychoudhury, S; Taphoorn, MJB; Velikova, G; Wintner, LM; Griebsch, I; Bottomley, A; SISAQOL-IMI Consortium: Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures. Lancet Oncol. 2023; 24(6); e270-e283. doi: 10.1016/S1470-2045(23)00157-2.
• Efficace, F; Buckstein, R; Abel, GA; Giesinger, JM; Fenaux, P; Bewersdorf, JP; Brunner, AM; Bejar, R; Borate, U; DeZern, AE; Greenberg, P; Roboz, GJ; Savona, MR; Sparano, F; Boultwood, J; Komrokji, R; Sallman, DA; Xie, Z; Sanz, G; Carraway, HE; Taylor, J; Nimer, SD; Della Porta, MG; Santini, V; Stahl, M; Platzbecker, U; Sekeres, MA; Zeidan, AM: Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/ neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS). . Hemasphere. 2024;8(5); e69. doi: 10.1002/hem3.69.
• Lehmann, J; Pilz, MJ; Holzner, B; Kemmler, G; Giesinger, JM: General population normative data from seven European countries for the K10 and K6 scales for psychological distress. Sci Rep. 2023; 13(1); 18389. doi: 10.1038/s41598-023-45124-0.

Psychooncology and Health-Utility Research

• Oberguggenberger, AS; Engele, VI; Schmalz, C; Nordin, A; Bjelic-Radisic, V; Lanceley, A; Kuljanic, K; Jensen, PT; Frøding, LP; Creutzberg, CL; Zimmermann, K; Serpentini, S; Arraras, JI; Nagele, E; Toelen, H; Greimel, E; EORTC Quality of Life Group: The impact of curative cancer treatment on sexual health – clinical results from the EORTC QLQ-SH22 validation study. BMC Cancer. 2024;24(1); 1374. doi: 10.1186/s12885-024-13123-7.
• Brunner, C; Egle, D; Ritter, M; Kofler, R; Giesinger, JM; Schneitter, L; Sztankay, M; Emmelheinz, M; Abdel Azim, S; Wieser, V; Oberguggenberger, A: PRO Hair Safe Study: The Patient’s Perspective on the Effects of Scalp Cooling on Hair Preservation. Breast Cancer (Dove Med Press). 2023; 15; 485-494. doi: 10.2147/BCTT.S412338.
• Seyringer, S; Pilz, MJ; Jansen, F; Büttner, M; King, MT; Norman, R; Kemmler, G; Nerich, V; Holzner, B; Bottomley, A; Gamper, EM; EORTC Quality of Life Group: Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence. Eur J Cancer. 2025; 217; 115235. doi: 10.1016/j.ejca.2025.115235.
• Seyringer, S; Pilz, MJ; Bottomley, A; King, MT; Norman, R; Gamper, EM; EORTC Quality of Life Group: Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma. Eur J Health Econ. 2024; Nov 20. doi: 10.1007/s10198-024-01729-4.
• Pilz, MJ; Seyringer, S; Al-Naesan, I; King, MT; Bottomley, A; Norman, R; Schlosser, L; Hell, T; Gamper, EM; EORTC Quality of Life Group: Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs. Pharmacoecon Open. 2024;8(4); 627-640. doi: 10.1007/s41669-024-00484-9.

Electronic PRO Assessment Tools

• Lehmann, J; de Ligt, KM; Tipelius, S; Giesinger, JM; Sztankay, M; Voigt, S; van de Poll-Franse, LV; Rumpold, G; Weger, R; Willenbacher, E; Willenbacher, W; Holzner, B: Adherence to Patient-Reported Symptom Monitoring and Subsequent Clinical Interventions for Patients With Multiple Myeloma in Outpatient Care: Longitudinal Observational Study. J Med Internet Res. 2023; 25; e46017. doi: 10.2196/46017.
• Lehmann, J; Dragan, T; Rammant, E; de Ligt, KM; Lai-Kwon, J; Lidington, E; Bultijnck, R; Dejaco, D; Taylor, KJ; Gašpert, T; Colombo, E; Madariaga, A; Brandão, M; Nicolay, JP; Zerdes, I; Bosisio, F; Correia, D; Pellerino, A; Marquina, G; Fontes-Sousa, M; Grisay, G; Silva, T; Siebenhüner, A; Cammarota, A; Szturz, P: Exploring the integration of patient-reported outcome measures in clinical practice: A cross-sectional survey of EORTC healthcare professionals. Eur J Cancer. 2025; Mar 1; 220:115333. doi: 10.1016/j.ejca.2025.115333.
• Riedl, D; Lehmann, J; Rothmund, M; Dejaco, D; Grote, V; Fischer, MJ; Rumpold, G; Holzner, B; Licht, T: Usability of Electronic Patient-Reported Outcome Measures for Older Patients With Cancer: Secondary Analysis of Data from an Observational Single Center Study. J Med Internet Res. 2023; 25; e49476. doi: 10.2196/49476.
• Lehmann, J; de Ligt, KM; Tipelius, S; Giesinger, JM; Sztankay, M; Voigt, S; van de Poll-Franse, LV; Rumpold, G; Weger, R; Willenbacher, E; Willenbacher, W; Holzner, B: Adherence to Patient-Reported Symptom Monitoring and Subsequent Clinical Interventions for Patients With Multiple Myeloma in Outpatient Care: Longitudinal Observational Study. J Med Internet Res. 2023; 25; e46017. doi: 10.2196/46017.

Psychotherapy and Trauma Research

• Kampling, H; Riedl, D; Lampe, A; Nolte, T; Brähler, E; Ernst, M; Fegert, JM; Geisel, T; Hettich-Damm, N; Jud, A; Zara, S; Kruse, J: Somatic symptom disorder and the role of epistemic trust, personality functioning and child abuse: Results from a population-based representative German sample. Journal of Affective Disorders. 2025; 373; 429–437. https://doi.org/10.1016/j.jad.2024.12.096.
• Lampe, A; Riedl, D; Kampling, H; Nolte, T; Kirchhoff, C; Grote, V; Fischer, MJ; Kruse, J: Improvements of complex post-traumatic stress disorder symptoms during a multimodal psychodynamic inpatient rehabilitation treatment – results of an observational single-centre pilot study. European Journal of Psychotraumatology. 2024; 15(1); 2333221. https://doi.org/10.1080/20008066.2024.2333221.
• Riedl, D; Kampling, H; Nolte, T; Kirchhoff, C; Kruse, J; Sachser, C; Fegert, JM; Gündel, H; Brähler, E; Grote, V; Fischer, MJ; Lampe, A: Utilization of Mental Health Provision, Epistemic Stance and Comorbid Psychopathology of Individuals with Complex Post-Traumatic Stress Disorders (CPTSD)-Results from a Representative German Observational Study. Journal of Clinical Medicine. 2024; 13(10); 2735. https://doi.org/10.3390/jcm13102735.
• Riedl, D; Labek, K; Gstrein, I; Rothmund, MS; Sperner-Unterweger, B; Kantner-Rumplmair, W: Large improvement of mental health during in outpatient short-term group psychotherapy treatment-a naturalistic pre-/post-observational study. Neuropsychiatrie. 2023; 37(2); 57–64. https://doi.org/10.1007/s40211-022-00449-6.
• Riedl, D; Kampling, H; Kruse, J; Nolte, T; Labek, K; Kirchhoff, C; Grote, V; Fischer, MJ; Knipel, A; Lampe, A: Epistemic Trust Is a Critical Success Factor in Psychosomatic Rehabilitation-Results from a Naturalistic Multi-Center Observational Study. Journal of Clinical Medicine. 2023; 13(1); 177. https://doi.org/10.3390/jcm13010177.

Sports Psychiatry

• Burtscher, J; Denti, V; Gostner, JM; Weiss, AK; Strasser, B; Hüfner, K; Burtscher, M; Paglia, G; Kopp, M; Dünnwald, T: The interplay of NAD and hypoxic stress and its relevance for ageing. Ageing Res Rev. 2025; 104:102646. doi: 10.1016/j.arr.2024.102646. Epub 2024 Dec 20.
• Burtscher, J; Miskowiak, KW; Hüfner, K; Ehrenreich, H; Kopp, M: The potential role of mitochondria in age-related health benefits conferred by moderate hypoxia. Gerontology. 2025; May 26;1-14. doi: 1159/000546478.
• Burtscher, J; Gassmann, M; Ehrenreich, H; Hüfner, K; Kopp, M; Burtscher, M: Cognitive effects of altitude exposure. J Travel Med. 2025; 32(5): taae112. doi: 1093/jtm/taae112.
• Burtscher, J; Citherlet, T; Camacho-Cardenosa, A; Camacho-Cardenosa, M; Raberin, A; Krumm, B; Hohenauer, E; Egg, M; Lichtblau, M; Müller, J; Rybnikova, EA; Gatterer, H; Debevec, T; Baillieul, S; Manferdelli, G; Behrendt, T; Schega, L; Ehrenreich, H; Millet, GP; Gassmann, M; Schwarzer, C; Glazachev, O; Girard, O; Lalande, S; Hamlin, M; Samaja, M; Hüfner, K; Burtscher, M; Panza, G; Mallet, RT: Mechanisms underlying the health benefits of intermittent hypoxia conditioning. J Physiol. 2024; 602(21); 5757-5783. doi: 10.1113/JP285230.
• Salvotti, HV; Tymoszuk, P; Ströhle, M; Paal, P; Brugger, H; Faulhaber, M; Kugler, N; Beck, T; Sperner-Unterweger, B; Hüfner K: Three distinct patterns of mental health response following accidents in mountain sports: a follow-up study of individuals treated at a tertiary trauma center. Eur Arch Psychiatry Clin Neurosci. 2024; 274(6); 1289-1310. doi: 10.1007/s00406-024-01807-x. Epub 2024 May 10.
• Falla, M; van Veelen, MJ; Falk, M; Weiss, EM; Roveri, G; Masè, M; Weber, B; Randi, A; Brugger, H; Hüfner, K; Strapazzon G: Effect of oxygen supplementation on cognitive performance among HEMS providers after acute exposure to altitude: the HEMS II randomized clinical trial. Scand J Trauma Resusc Emerg Med. 2024; 32(1); 65. doi: 10.1186/s13049-024-01238-6.
• Gstir, C; Schurr, T; Ehlers, R; Burtscher, J; Sperner-Unterweger, B; Hüfner, K: Is it Possible for Individuals with Pre-Existing Mental Disorders to Perform Mountain Sports at High Altitude-First Evidence from a Pilot Cross-Sectional Questionnaire Study. High Alt Med Biol. 2024; Oct 9. doi: 10.1089/ham.2024.0056.
• Gerrido, E; Hüfner, K: An Episode of “Third Person” Phenomenon Involving Somesthetic and Visual Hallucinations in a World-Class Extreme Altitude Climber. Wilderness Environ Med. 2023; 34(4); 549-552. doi: 1016/j.wem.2023.07.004. Hüfner, K; Falla, M; Brugger, H; Gatterer, H; Strapazzon, G; Tomazin, I; Zafren, K; Sperner-Unterweger, B; Fusar-Poli, P: Isolated high altitude psychosis, delirium at high altitude, and high altitude cerebral edema: are these diagnoses valid? Front Psychiatry. 2023; 14; 1221047. doi: 10.3389/fpsyt.2023.1221047.

Stress-Related Disorders and Psychoneuroimmunology

• Salzmann, S; de Vroege, L; Engelmann, P; Fink, P; Fischer, S; Frisch, S; Gormsen, LK; Hüfner, K; Kop, WJ; Köteles, F; Lehnen, N; Löwe, B; Pieh, C; Pitron, V; Rask, CU; Sainio, M; Schaefert, R; Shedden-Mora, M; Toussaint, A; von Känel, R; Werneke, U; Rief, W; EURONET-SOMA Group: Assessment of psychosocial aspects in adults in post-COVID-19 condition: the EURONET-SOMA recommendations on core outcome domains for clinical and research use. BMC Med. 2025; 23(1); 81. doi: 10.1186/s12916-025-03927-0.
• Toussaint, A; Weigel, A; Löwe, B; EURONET-SOMA group: The overlooked burden of persistent physical symptoms: a call for action in European healthcare. Lancet Reg Health Eur. 2024; 48; 101140. doi: 10.1016/j.lanepe.2024.101140.
• Hüfner, K; Vedova, S; Tymoszuk, P; Nelles, P; Bruckner, T; Deisenhammer, EA; Egeter, J; Galffy, M; Giesinger, JM; Lehmann, J; Oberhammer, M; Rockenschaub, J; Sacher, M; Holzner, B; Gostner, JM; Sperner-Unterweger, B: The effect of inflammation, SARS-CoV-2 infection, age and mental health on serotonin, and kynurenine and catecholamine pathway metabolites. Psychoneuroendocrinology. 2023; 156; 106334. doi: 10.1016/j.psyneuen.2023.106334.
• Hüfner, K; Tymoszuk, P; Sahanic, S; Luger, A; Boehm, A; Pizzini, A; Schwabl, C; Koppelstätter, S; Kurz, K; Asshoff, M; Mosheimer-Feistritzer, B; Pfeifer, B; Rass, V; Schroll, A; Iglseder, S; Egger, A; Wöll, E; Weiss, G; Helbok, R; Widmann, G; Sonnweber, T; Tancevski, I; Sperner-Unterweger, B; Löffler-Ragg, J: Persistent somatic symptoms are key to individual illness perception at one year after COVID-19 in a cross-sectional analysis of a prospective cohort study. J Psychosom Res. 2023; 169;111234. doi: 10.1016/j.jpsychores.2023.111234.
• Sahanic, S; Tymoszuk, P; Luger, AK; Hüfner, K; Boehm, A; Pizzini, A; Schwabl, C; Koppelstätter, S; Kurz, K; Asshoff, M; Mosheimer-Feistritzer, B; Coen, M; Pfeifer, B; Rass, V; Egger, A; Hörmann, G; Sperner-Unterweger, B; Helbok, R; Wöll, E; Weiss, G; Widmann, G; Tancevski, I; Sonnweber T; Löffler-Ragg J: COVID-19 and its continuing burden after 12 months: a longitudinal observational prospective multicentre trial. ERJ Open Res. 2023; 9(2); 00317-2022. doi: 10.1183/23120541.00317-2022.
• Rass, V; Tymoszuk, P; Sahanic, S; Heim, B; Ausserhofer, D;  Lindner, A; Kofler, M; Mahlknecht, P; Boehm, A; Hüfner, K; Pizzini, A; Sonnweber, T; Kurz, K; Pfeifer, B; Kiechl, S; Peball, M; Kindl, P; Putnina, L;  Fava, E; Djamshidian, A; Huber, A; Wiedermann, CW; Sperner-Unterweger, B; Wöll, E; Beer, R; Schiefecker, AJ; Bellmann-Weiler, R;  Bachler, H; Tancevski, I; Pfausler, B; Piccoliori, G; Seppi, K; Weiss, G; Löffler-Ragg, J; Helbok, R: Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae. Eur Arch Otorhinolaryngol. 2023; Nov;280(11): 5115-5128. doi: 10.1007/s00405-023-08163-x.
• Rabady, S; Hoffmann, K; Aigner, M; Altenberger, J; Brose, M; Costa, U; Denk-Linnert, DM; Gruber, S; Götzinger, F; Helbok, R; Hüfner, K; Koczulla, R; Kurz, K; Lamprecht, B; Leis, S; Löffler, J; Müller, CA; Rittmannsberger, H; Rommer, PS; Sator, P; Strenger, V; Struhal, W; Untersmayr, E; Vonbank, K; Wancata, J; Weber, T; Wendler, M; Zwick, RH: [S1 guidelines for the management of postviral conditions using the example of post-COVID-19]. Wien Klin Wochenschr. 2023; Jul;135(Suppl 4); 525-598. doi: 10.1007/s00508-023-02242-z.
• Sahanic, S; Tymoszuk, P; Luger, AK; Hüfner, K; Boehm, A; Pizzini, A; Schwabl, C; Koppelstätter, S; Kurz, K; Asshoff, M; Mosheimer-Feistritzer, B; Coen, M; Pfeifer, B; Rass, V; Egger, A; Hörmann, G; Sperner-Unterweger, B; Helbok, R; Wöll, E; Weiss, G; Widmann, G; Tancevski, I; Sonnweber, T; Löffler-Ragg, J; COVID-19 and its continuing burden after 12 months: a longitudinal observational prospective multicentre trial. ERJ Open Res. 2023; 9(2); 00317-2022. doi: 10.1183/23120541.00317-2022.

Well-being of medical students

• Huber, A; Rabl, L; Höge-Raisig T; Höfer, S: Well-being, Mental Health and Study Characteristics of Medical Students before and during the Pandemic. Behavioral Sciences, 2024; 14(1); 7. DOI: 10.3390/bs14010007.

Gamper E. EORTC – European Organisation for Research and Treatment of Cancer: Assessing Measurement Invariance and Utility Assignment Effects of the QLU-C10D Across Demographic and Clinical Subgroups. Funding period 2025 – 2028

Giesinger JM. OeAD-KOEFF: Cross-cultural investigation of symptoms and functional health of cancer patients in Europe and in the Democratic Republic of the Congo. Funding period: 2024-2026

Holzner B. EORTC – European Organisation for Research and Treatment of Cancer: An international field study for the reliability and validity of the EORTC Ophthalmic Oncology Quality of Life questionnaire Module (QLQ-OPTXX) including an update of phase 1-3. Funding period: 2023-2026

Huber A. Medical University Innsbruck: KI-basierte Kommunikation. Funding period: 2024–2025

Hüfner K. Austrian Academy of Sciences: ESS22-30-KIDZ PAZ-NOWn, Resilience of Mountain Regions: interdisciplinary and transdisciplinary approaches. Funding period: 2022-2026

Hüfner K. Austrian Science Fund– FWF: Translational Epigenetics in Anxiety disorders (PAT6749924). Funding Period: 2025-2028

Hüfner K. State of Tyrol: Exercise is Medicine (EiM; P6210-046-012). Funding period: 2024–2027

Kumnig M. US Office of the Assistant Secretary of Defense for Health Affairs under the Reconstructive Transplant Research Program—Qualitative Research Award No. W81XWH-17-1-0400. Funding period: 2021-2024

Riedl D. EU (Horizon Europe): MONALISA – A SIOPEN pragmatic clinical trial to Monitor Neuroblastom A relapse with Liquid biopsy Sensitive Analysis. Funding period: 2024-2028

Winter L, Giesinger J, Holzner B. European Union’s Horizon 2020 (Innovative Health Initiative): Setting International Standards in Analysing Patient-Reported Outcomes and Quality of Life Endpoints – SISAQOL-IMI (No 945052). Funding period: 2021-2025

• Beth Israel Deaconess Medical Center, Boston, MA, United States
• Center for Survey Research, Research Center for Humanities and Social Sciences, Academia Sinica, Taipei, Taiwan
• Department for Internal Medicine, County Hospital Kufstein, Kufstein, Austria
• Department of Education and Psychology, Division of Clinical Psychological Intervention, Freie Universität Berlin, Berlin, Germany
• Department of Psychology, University Innsbruck, Innsbruck, Austria
• Department of Psychosomatic Medicine and Psychotherapy, Justus Liebig University Giessen, Giessen, Germany
• Department of Sport Science, University Innsbruck, Innsbruck, Austria
• European Association of Psychosomatic Medicine – Euronet SOMA Group, Innsbruck, Austria
• European Organization of Research and Treatment of Cancer (EORTC) – Quality of Life Group University of Sydney, Sydney, Australia
• Freud National Centre for Children and Families, London, United Kingdom
• Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA), Rome, Italy
• Institute of Mountain Emergency Medicine, EURAC Research, Bolzano, Italy
• Ludwig-Boltzmann Institute for Rehabilitation Research, Ludwig Boltzmann Society, Vienna, Austria
• Österreichische Plattform für Psychoonkologie (ÖPPO), Innsbruck, Austria
• Parnassia Psychiatric Institute, The Hague, Netherlands
• Research Department of Clinical, Educational and Health Psychology, UCL, London, United Kingdom